Physiology of testicular steroidogenesis

Knobil and Neill's Physiology of Reproduction

Volumn , Issue , 2006, Pages 977-1016

  Stocco, Douglas M ^a   McPhaul, Michael J ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847612517     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012515400-0/50025-7     Document Type: Chapter

References (496)

1. Eik-Nes K.B., Hall P.F. Secretion of steroid hormones in vivo. Vitam. Horm. 1965, 23:153-208.
2. 14C in vitro. Endocrinology 1965, 76:646-656.
3. Dufau M.L., Veldhuis J.D., Fraioli F., Johnson M.L., Beitins I.Z. Mode of secretion of bioactive luteinizing hormone in man. J. Clin. Endocrinol. Metab. 1983, 57:993-1003.
4. Dufau M. The luteinizing hormone receptor. The Leydig Cell 1996, 333-350. Cache River Press, Clearwater, FL. A.H. Payne, M.P. Hardy, L.D. Russell (Eds.).
5. Ascoli M., Fanelli F., Segaloff D.L. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 2002, 23:141-174.
6. Neill J.D., Patton J.M., Dailey R.A., Tsou R.C., Tindall G.T. Luteinizing hormone releasing hormone (LHRH) in pituitary stalk blood of rhesus monkeys: relationship to level of LH release. Endocrinology 1977, 101:430-434.
7. Dufau M.L., Tsuruhara T., Horner K.A., Podesta E., Catt K.J. Intermediate role of adenosine 3′:5′-cyclic monophosphate and protein kinase during gonadotropin-induced steroidogenesis in testicular interstitial cells. Proc Natl Acad Sci U S A 1977, 74:3419-3423.
8. Zhang F.P., Poutanen M., Wilbertz J., Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol. Endocrinol. 2001, 15:172-183.
9. Lei Z.M., Mishra S., Zou W., Xu B., Foltz M., Li X., Rao C.V. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol. Endocrinol. 2001, 15:184-200.
10. O'Shaughnessy P.J., Baker P., Sohnius U., Haavisto A.M., Charlton H.M., Huhtaniemi I. Fetal development of Leydig cell activity in the mouse is independent of pituitary gonadotroph function. Endocrinology 1998, 139:1141-1146.
11. Baker P.J., O'Shaughnessy P.J. Role of gonadotrophins in regulating numbers of Leydig and Sertoli cells during fetal and postnatal development in mice. Reproduction 2001, 122:227-234.
12. O'Shaughnessy P.J., Fleming L.M., Jackson G., Hochgeschwender U., Reed P., Baker P.J. Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology 2003, 144:3279-3284.
13. Cooke B.A. Transduction of the luteinizing hormone signal within the Leydig cell. The Leydig Cell 1996, 351-364. Cache River Press, Vienna, IL. A.H. Payne, M.P. Hardy, L.D. Russell (Eds.).
14. Ford S.L., Reinhart A.J., Lukyanenko Y., Hutson J.C., Stocco D.M. Pregnenolone synthesis in immature rat Sertoli cells. Mol. Cell. Endocrinol. 1999, 157:87-94.
15. Dorrington J.H., Armstrong D.T. Follicle-stimulating hormone stimulates estradiol-17beta synthesis in cultured Sertoli cells. Proc. Natl. Acad. Sci. U S A 1975, 72:2677-2681.
16. Nyman M.A., Geiger J., Goldzieher J.W. Biosynthesis of estrogen by the perfused stallion testis. J. Biol. Chem. 1959, 234:16-18.
17. Ritzen E.M., Van Damme M.P., Froysa B., Reuter C., De La Torre B., Diczfalusy E. Identification of estradiol produced by Sertoli cell enriched cultures during incubation with testosterone. J. Steroid Biochem. 1981, 14:533-535.
18. Canick J.A., Makris A., Gunsalus G.L., Ryan K.J. Testicular aromatization in immature rats: localization and stimulation after gonadotropin administration in vivo. Endocrinology 1979, 104:285-288.
19. Payne A.H., O'Shaughnessy P.J. Structure, function and regulation of steroidogenic enzymes in the Leydig cell. The Leydig Cell 1996, 259-286. Cache River Press, Vienna, IL. A.H. Payne, M.P. Hardy, L.D. Russell (Eds.).
20. Swerdloff R.S., Wang C. Clinical evaluation of Leydig cell function. The Leydig Cell 1996, 663-694. Cache River Press, Vienna, IL. A.H. Payne, M.P. Hardy, L.D. Russell (Eds.).
21. Hall P.F. Testicular steroid synthesis: organization and regulation. The Physiology of Reproduction 1994, 1335-1362. Raven Press, Vienna, IL. E. Knobil, J.D. Neill (Eds.).
22. Rudney H., Sexton R.C. Regulation of cholesterol biosynthesis. Annu. Rev. Nutr. 1986, 6:245-272.
23. Rudney H., Pannini R. Cholesterol biosynthesis. Curr. Opin. Lipidol. 1993, 4:230-237.
24. Goldstein J.L., Brown M.S., Anderson R.G., Russell D.W., Schneider W.J. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu. Rev. Cell. Biol. 1985, 1:1-39.
25. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
26. Andersen J.M., Dietschy J.M. Relative importance of high and low density lipoproteins in the regulation of cholesterol synthesis in the adrenal gland, ovary, and testis of the rat. J. Biol. Chem. 1978, 253:9024-9032.
27. Kovanen P.T., Schneider W.J., Hillman G.M., Goldstein J.L., Brown M.S. Separate mechanisms for the uptake of high and low density lipoproteins by mouse adrenal gland in vivo. J. Biol. Chem. 1979, 254:5498-5505.
28. Spady D.K., Meddings J.B., Dietschy J.M. Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster. J. Clin. Invest. 1986, 77:1474-1481.
29. Glass C., Pittman R.C., Weinstein D.B., Steinberg D. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc. Natl. Acad. Sci. U S A 1983, 80:5435-5439.
30. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271:518-520.
31. Reaven E., Tsai L., Azhar S. Intracellular events in the "selective" transport of lipoprotein-derived cholesteryl esters. J. Biol. Chem. 1996, 271:16208-16217.
32. Graf G.A., Connell P.M., van der Westhuyzen D.R., Smart E.J. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae. J. Biol. Chem. 1999, 274:12043-12048.
33. Azhar S., Nomoto A., Leers-Sucheta S., Reaven E. Simultaneous induction of an HDL receptor protein (SR-BI) and the selective uptake of HDL-cholesteryl esters in a physiologically relevant steroidogenic cell model. J. Lipid Res. 1998, 39:1616-1628.
34. Reaven E., Nomoto A., Leers-Sucheta S., Temel R., Williams D.L., Azhar S. Expression and microvillar localization of scavenger receptor, class B, type I (a high density lipoprotein receptor) in luteinized and hormone-desensitized rat ovarian models. Endocrinology 1998, 139:2847-2856.
35. Ikemoto M., Arai H., Feng D., Tanaka K., Aoki J., Dohmae N., Takio K., Adachi H., Tsujimoto M., Inoue K. Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc. Natl. Acad. Sci. U S A 2000, 97:6538-6543.
36. Azhar S., Leers-Sucheta S., Reaven E. Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and 'selective' pathway connection. Front Biosci. 2003, 8:s998-s998029.
37. Azhar S., Reaven E. Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis. Mol. Cell. Endocrinol. 2002, 195:1-26.
38. 3H]cholesteryl linoleyl ether or with I by cultured rat hepatocytes and adrenal cells. Biochim. Biophys. Acta. 1984, 796:72-82.
39. Leitersdorf E., Israeli A., Stein O., Eisenberg S., Stein Y. The role of apolipoproteins of HDL in the selective uptake of cholesteryl linoleyl ether by cultured rat and bovine adrenal cells. Biochim. Biophys. Acta. 1986, 878:320-329.
40. Pittman R.C., Glass C.K., Atkinson D., Small D.M. Synthetic high density lipoprotein particles. Application to studies of the apoprotein specificity for selective uptake of cholesterol esters. J. Biol. Chem. 1987, 262:2435-2442.
41. Pittman R.C., Knecht T.P., Rosenbaum M.S., Taylor C.A. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J. Biol. Chem. 1987, 262:2443-2450.
42. Gwynne J.T., Mahaffee D.D. Rat adrenal uptake and metabolism of high density lipoprotein cholesteryl ester. J. Biol. Chem. 1989, 264:8141-8150.
43. Green S.R., Pittman R.C. Selective uptake of cholesteryl esters from low density lipoproteins in vitro and in vivo. J. Lipid Res. 1991, 32:667-678.
44. Cherradi N., Bideau M., Arnaudeau S., Demaurex N., James R.W., Azhar S., Capponi A.M. Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I. Endocrinology 2001, 142:4540-4549.
45. Azhar S., Tsai L., Reaven E. Uptake and utilization of lipoprotein cholesteryl esters by rat granulosa cells. Biochim. Biophys. Acta. 1990, 1047:148-160.
46. Reaven E., Tsai L., Azhar S. Cholesterol uptake by the 'selective' pathway of ovarian granulosa cells: early intracellular events. J. Lipid Res. 1995, 36:1602-1617.
47. Reaven E., Zhan L., Nomoto A., Leers-Sucheta S., Azhar S. Expression and microvillar localization of scavenger receptor class B, type I (SR-BI) and selective cholesteryl ester uptake in Leydig cells from rat testis. J. Lipid Res. 2000, 41:343-356.
48. Rigotti A., Miettinen H.E., Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 2003, 24:357-387.
49. Christenson L.K., Devoto L. Cholesterol transport and steroidogenesis by the corpus luteum. Reprod. Biol. Endocrinol. 2003, 1:90.
50. Maxfield F.R., Wustner D. Intracellular cholesterol transport. J. Clin. Invest. 2002, 110:891-898.
51. Srere P., Chaikoff I., Dauben W. The in vitro synthesis of cholesterol from acetate by surviving adrenal cortical tissue. J. Biol. Chem. 1948, 176:829-833.
52. Srere P. The extrahepatic synthesis of cholesterol. J. Biol. Chem. 1950, 182:629-645.
53. Savard K. Biogenesis of androgens in the human testis. J. Clin. Endocrinol. 1952, 12:935.
54. Morris M.D., Chaikoff I.L. The origin of cholesterol in liver, small intestine, adrenal gland, and testis of the rat: dietary versus endogenous contributions. J. Biol. Chem. 1959, 234:1095-1097.
55. Azhar S., Menon K.M. Receptor mediated gonadotropin action in gonadal tissues: relationship between blood cholesterol levels and gonadotropin stimulated steroidogenesis in isolated rat Leydig and luteal cells. J. Steroid Biochem. 1982, 16:175-184.
56. Hou J.W., Collins D.C., Schleicher R.L. Sources of cholesterol for testosterone biosynthesis in murine Leydig cells. Endocrinology 1990, 127:2047-2055.
57. Quinn P.G., Dombrausky L.J., Chen Y.D., Payne A.H. Serum lipoproteins increase testosterone production in hCG-desensitized Leydig cells. Endocrinology 1981, 109:1790-1792.
58. Charreau E.H., Calvo J.C., Nozu K., Pignataro O., Catt K.J., Dufau M.L. Hormonal modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in gonadotropin-stimulated and -desensitized testicular Leydig cells. J. Biol. Chem. 1981, 256:12719-12724.
59. Freeman D.A., Ascoli M. Studies on the source of cholesterol used for steroid biosynthesis in cultured Leydig tumor cells. J. Biol. Chem. 1982, 257:14231-14238.
60. Schreiber J.R., Weinstein D.B., Hsueh A.J. Lipoproteins stimulate androgen production by cultured rat testis cells. J. Steroid Biochem. 1982, 16:39-43.
61. Klinefelter G.R., Ewing L.L. Optimizing testosterone production by purified adult rat Leydig cells in vitro. In Vitro Cell. Dev. Biol. 1988, 24:545-549.
62. Risbridger G.P., Hedger M.P. Adult rat Leydig cell cultures: minimum requirements for maintenance of luteinizing hormone responsiveness and testosterone production. Mol. Cell. Endocrinol. 1992, 83:125-132.
63. Hedger M.P., Risbridger G.P. Effect of serum and serum lipoproteins on testosterone production by adult rat Leydig cells in vitro. J. Steroid. Biochem. Mol. Biol. 1992, 43:581-589.
64. Landschulz K.T., Pathak R.K., Rigotti A., Krieger M., Hobbs H.H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 1996, 98:984-995.
65. Benahmed M., Reventos J., Saez J.M. Steroidogenesis of cultured purified pig Leydig cells: effects of lipoproteins and human chorionic gonadotropin. Endocrinology 1983, 112:1952-1957.
66. Carr B.R., Parker C.R., Ohashi M., MacDonald P.C., Simpson E.R. Regulation of human fetal testicular secretion of testosterone: low-density lipoprotein-cholesterol and cholesterol synthesized de novo as steroid precursor. Am. J. Obstet. Gynecol. 1983, 146:241-247.
67. Slaunwhite W.R., Samuels L.T. Progesterone as a precursor of testicular androgens. J. Biol. Chem. 1956, 220:341-352.
68. 14C]progesterone by rat testis interstitium in vitro. Biochim. Biophys. Acta. 1968, 164:412-420.
69. Tamaoki B. In vitro synthesis and conversion of androgen in testicular tissue. The Gonads 1969, 547-613. Appleton, New York. K.W. McKerns (Ed.).
70. Kwan T.K., Pertiwi A.K., Taylor N.F., Gower D.B. Steroid profiling in the study of rat testicular steroidogenesis. Biochim. Biophys. Acta. 1988, 962:214-219.
71. Eik-Nes K.B. Synthesis and secretion of androstenedione and testosterone. The Androgens of the Testis 1970, 10-14. Dekker, New York. K.B. Eik-Nes (Ed.).
72. Hall P.F., Sozer C.C., Eik-Nes K.B. Formation of dehydroepiandrosterone during in vivo and in vitro biosynthesis of testosterone by testicular tissue. Endocrinology 1964, 74:35-43.
73. Booth W.D. Changes with age in the occurrence of C19 steroids in the testis and submaxillary gland of the boar. J. Reprod. Fertil. 1975, 42:459-472.
74. Vihko R. Regulation of steroidogenesis in testis. J. Steroid Biochem. 1974, 5:843-847.
75. Preslock J.P., Steinberger E. Testicular steroidogenesis in the common marmoset, Callithrix jacchus. Biol. Reprod. 1977, 17:289-293.
76. Preslock J.P. In vitro steroidogenesis in subhuman primates. Testicular Development, Structure and Function 1980, 249-268. Raven, New York. E. Steinberger, A. Steinberger (Eds.).
77. Hammar M., Petersson F. Testosterone production in vitro in human testicular tissue. Andrologia 1986, 18:196-200.
78. Rajfer J., Sikka S.C., Swerdloff R.S. Lack of a direct effect of gonadotropin hormone-releasing hormone agonist on human testicular steroidogenesis. J. Clin. Endocrinol. Metab. 1987, 64:62-67.
79. Rey R., Campo S., Ayuso S., Nagle C., Chemes H. Testicular steroidogenesis in the Cebus monkey throughout postnatal development. Biol Reprod. 1995, 52:997-1002.
80. Wilson J.D., Auchus R.J., Leihy M.W., Guryev O.L., Estabrook R.W., Osborn S.M., Shaw G., Renfree M.B. 5alpha-androstane-3alpha,17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediate. Endocrinology 2003, 144:575-580.
81. Mahendroo M., Wilson J.D., Richardson J.A., Auchus R.J. Steroid 5alpha-reductase 1 promotes 5alpha-androstane-3alpha,17beta-diol synthesis in immature mouse testes by two pathways. Mol. Cell. Endocrinol. 2004, 222:113-120.
82. Jefcoate C.R. Regulation of cholesterol movement to mitochondrial cytochrome P450scc in steroid hormone synthesis. J. Steroid Biochem. Mol. Biol. 1992, 43:751-767.
83. Lambeth J.D. Cytochrome P-450scc: Enzymology, and the regulation of intramitochondrial delivery to the enzyme. Endocr. Res. 1985, 10:283-309.
84. Orme-Johnson N.R. Distinctive properties of adrenal cortex mitochondria. Biochim Biophys. Acta. 1990, 1020:213-231.
85. Hanukoglu I., Jefocate C.R. Mitochondrial cytochrome P-450scc. Mechanism of electron transport by adrenodoxin. J. Biol. Chem. 1980, 255:3057-3061.
86. Hanukoglu I., Spitsberg V., Bumpus J.A., Dus K.M., Jefcoate C.R. Adrenal mitochondrial cytochrome P-450scc. Cholesterol and adrenodoxin interactions at equilibrium and during turnover. J. Biol. Chem. 1981, 256:4321-4328.
87. Yago N., Ichii S. Submitochondrial distribution of components of the steroid 11 beta-hydroxylase and cholesterol sidechain-cleaving enzyme systems in hog adrenal cortex. J. Biochem. (Tokyo). 1969, 65:215-224.
88. Churchill P.F., Kimura T. Topological studies of cytochromes P-450scc and P-45011 beta in bovine adrenocortical inner mitochondrial membranes. Effects of controlled tryptic digestion. J. Biol. Chem. 1979, 254:10443-10448.
89. Farkash Y., Timberg R., Orly J. Preparation of antiserum to rat cytochrome P-450 cholesterol side chain cleavage, and its use for ultrastructural localization of the immunoreactive enzyme by protein A-gold technique. Endocrinology 1986, 118:1353-1365.
90. Geuze H.J., Slot J.W., Yanagibashi K., McCracken J.A., Schwartz A.L., Hall P.F. Immunogold cytochemistry of cytochromes P-450 in porcine adrenal cortex. Two enzymes (side-chain cleavage and 11 beta-hydroxylase) are co-localized in the same mitochondria. Histochemistry 1987, 86:551-557.
91. O'Shaughnessy P.J., Murphy L. Steroidogenic enzyme activity in the rat testis following Leydig cell destruction by ethylene-1,2-dimethanesulphonate and during subsequent Leydig cell regeneration. J. Endocrinol. 1991, 131:451-457.
92. Schulster D. Biosynthesis of steroid hormones. Molecular Endocrinology of the Steroid Hormones 1976, 44-74. John Wiley & Sons, New York. D. Schulster, S. Burstein, B.A. Cooke (Eds.).
93. Boyd G.S., Simpson E.R. Studies on the conversion of cholesterol to pregnenolone in bovine adrenal mitochondria. Functions of the Adrenal Cortex 1968, Vol. 1:49-76. Appleton-Century-Crofts, New York. K.W. McKerns (Ed.).
94. Burstein S., Gut M. Intermediates in the conversion of cholesterol to pregnenolone: kinetics and mechanism. Steroids 1976, 28:115-131.
95. Shikita M., Hall P.F. Cytochrome P-450 from bovine adrenocortical mitochondria: an enzyme for the side chain cleavage of cholesterol. I. Purification and properties. J. Biol. Chem. 1973, 248:5598-5604.
96. Watanuki M., Granger G.A., Hall P.F. Cytochrome P-450 from bovine adrenocortical mitochondria. Immunochemical properties and purity. J. Biol. Chem. 1978, 253:2927-2931.
97. Black S.M., Harikrishna J.A., Szklarz G.D., Miller W.L. The mitochondrial environment is required for activity of the cholesterol side-chain cleavage enzyme, cytochrome P450scc. Proc. Natl. Acad. Sci. U S A 1994, 91:7247-7251.
98. Lambeth J.D., Pember S.O. Cytochrome P-450scc-adrenodoxin complex. Reduction properties of the substrate-associated cytochrome and relation of the reduction states of heme and iron-sulfur centers to association of the proteins. J. Biol. Chem. 1983, 258:5596-5602.
99. Porter T.D., Coon M.J. Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J. Biol. Chem. 1991, 266:13469-13472.
100. Picado-Leonard J., Voutilainen R., Kao L.C., Chung B.C., Strauss J.F., Miller W.L. Human adrenodoxin: cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells. J. Biol. Chem. 1988, 263:3240-3244.
101. Solish S.B., Picado-Leonard J., Morel Y., Kuhn R.W., Mohandas T.K., Hanukoglu I., Miller W.L. Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen-q25 are expressed in steroidogenic tissues. Proc. Natl. Acad. Sci. U S A 1988, 85:7104-7108.
102. Chang C.Y., Wu D.A., Lai C.C., Miller W.L., Chung B.C. Cloning and structure of the human adrenodoxin gene. DNA 1988, 7:609-615.
103. Lin D., Shi Y.F., Miller W.L. Cloning and sequence of the human adrenodoxin reductase gene. Proc. Natl. Acad. Sci. U S A 1990, 87:8516-8520.
104. Stone D., Hechter O. Studies on ACTH action in perfused bovine adrenals: the site of action of ACTH in corticosteroidogenesis. Arch. Biochem. 1954, 51:457-469.
105. Karaboyas G.C., Koritz S.B. The transformation of delta-5-pregnenolone and progesterone to cortisol by rat adrenal slices and the effect of ACTH and adenosine 3′-,5′-monophosphate upon it. Biochim. Biophys. Acta. 1965, 100:600-602.
106. Sulimovici S., Bartoov B., Lunenfeld B. Localization of 3-beta hydroxysteroid dehydrogenase in the inner membrane subfraction of rat testis mitochondria. Biochim. Biophys. Acta. 1973, 321:27-40.
107. Chapman J.C., Waterhouse T.B., Michael S.D. Changes in mitochondrial and microsomal 3 beta-hydroxysteroid dehydrogenase activity in mouse ovary over the course of the estrous cycle. Biol. Reprod. 1992, 47:992-997.
108. Cherradi N., Defaye G., Chambaz E.M. Characterization of the 3 beta-hydroxysteroid dehydrogenase activity associated with bovine adrenocortical mitochondria. Endocrinology 1994, 134:1358-1364.
109. Cherradi N., Chambaz E.M., Defaye G. Organization of 3 beta-hydroxysteroid dehydrogenase/isomerase and cytochrome P450scc into a catalytically active molecular complex in bovine adrenocortical mitochondria. J. Steroid Biochem. Mol. Biol. 1995, 55:507-514.
110. Sauer L.A., Chapman J.C., Dauchy R.T. Topology of 3 beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4-isomerase in adrenal cortex mitochondria and microsomes. Endocrinology 1994, 134:751-759.
111. Cherradi N., Rossier M.F., Vallotton M.B., Timberg R., Friedberg I., Orly J., Wang X.J., Stocco D.M., Capponi A.M. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome p450scc and 3beta-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells. J. Biol. Chem. 1997, 272:7899-7907.
112. Thomas J.L., Berko E.A., Faustino A., Myers R.P., Strickler R.C. Human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5-4-ene-isomerase: purification from microsomes, substrate kinetics, and inhibition by product steroids. J. Steroid Biochem. 1988, 31:785-793.
113. Ishii-Ohba H., Inano H., Tamaoki B. Testicular and adrenal 3 beta-hydroxy-5-ene-steroid dehydrogenase and 5-ene-4-ene isomerase. J. Steroid Biochem. 1987, 27:775-779.
114. Ishii-Ohba H., Saiki N., Inano H., Tamaoki B.I. Purification and characterization of rat adrenal 3 beta-hydroxysteroid dehydrogenase with steroid 5-ene-4-ene-isomerase. J. Steroid Biochem. 1986, 24:753-760.
115. Ford H.C., Engel L.L. Purification and properties of the delta 5-3 beta-hydroxysteroid dehydrogenase-isomerase system of sheep adrenal cortical microsomes. J. Biol. Chem. 1974, 249:1363-1368.
116. Rutherfurd K.J., Chen S.A., Shively J.E. Isolation and amino acid sequence analysis of bovine adrenal 3 beta-hydroxysteroid dehydrogenase/steroid isomerase. Biochemistry 1991, 30:8108-8116.
117. Rheaume E., Lachance Y., Zhao H.F., Breton N., Dumont M., de Launoit Y., Trudel C., Luu-The V., Simard J., Labrie F. Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol. Endocrinol. 1991, 5:1147-1157.
118. Lorence M.C., Murry B.A., Trant J.M., Mason J.I. Human 3 beta-hydroxysteroid dehydrogenase/delta 5-4 isomerase from placenta: expression in nonsteroidogenic cells of a protein that catalyzes the dehydrogenation/isomerization of C21 and C19 steroids. Endocrinology 1990, 126:2493-2498.
119. Lachance Y., Luu-The V., Labrie C., Simard J., Dumont M., de Launoit Y., Guerin S., Leblanc G., Labrie F. Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells. J. Biol. Chem. 1990, 265:20469-20475.
120. Simard J., de Launoit Y., Labrie F. Characterization of the structure-activity relationships of rat types I and II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase by site-directed mutagenesis and expression in HeLa cells. J. Biol. Chem. 1991, 266:14842-14845.
121. Lorence M.C., Naville D., Graham-Lorence S.E., Mack S.O., Murry B.A., Trant J.M., Mason J.I. 3 beta-hydroxysteroid dehydrogenase/delta 5-4-isomerase expression in rat and characterization of the testis isoform. Mol. Cell. Endocrinol. 1991, 80:21-31.
122. Clarke T.R., Bain P.A., Sha L., Payne A.H. Enzyme characteristics of two distinct forms of mouse 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase complementary deoxyribonucleic acids expressed in COS-1 cells. Endocrinology 1993, 132:1971-1976.
123. Luu-The V., Lachance Y., Labrie C., Leblanc G., Thomas J.L., Strickler R.C., Labrie F. Full length cDNA structure and deduced amino acid sequence of human 3 beta-hydroxy-5-ene steroid dehydrogenase. Mol. Endocrinol. 1989, 3:1310-1312.
124. Lachance Y., Luu-The V., Verreault H., Dumont M., Rheaume E., Leblanc G., Labrie F. Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity. DNA Cell. Biol. 1991, 10:701-711.
125. Lorence M.C., Corbin C.J., Kamimura N., Mahendroo M.S., Mason J.I. Structural analysis of the gene encoding human 3 beta-hydroxysteroid dehydrogenase/delta 5-4-isomerase. Mol. Endocrinol. 1990, 4:1850-1855.
126. Zhao H.F., Labrie C., Simard J., de Launoit Y., Trudel C., Martel C., Rheaume E., Dupont E., Luu-The V., Pelletier G., et al. Characterization of rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase cDNAs and differential tissue-specific expression of the corresponding mRNAs in steroidogenic and peripheral tissues. J. Biol. Chem. 1991, 266:583-593.
127. Bain P.A., Yoo M., Clarke T., Hammond S.H., Payne A.H. Multiple forms of mouse 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase and differential expression in gonads, adrenal glands, liver, and kidneys of both sexes. Proc. Natl. Acad. Sci. U S A 1991, 88:8870-8874.
128. Abbaszade I.G., Arensburg J., Park C.H., Clarke T., Kasa-Vubu J.Z., Orly J., Payne A.H. Isolation and tissue-specific expression of a mouse 3B-hydroxysteroid dehydrogenase isoform (3βHSD VI) that may be essential for implantation and/or maintenance of early pregnancy. 77th Annual Meeting of the Endocrine Society 1995, 619. Abstract #P613-P601.
129. Clarke T.R., Bain P.A., Greco T.L., Payne A.H. A novel mouse kidney 3 beta-hydroxysteroid dehydrogenase complementary DNA encodes a 3-ketosteroid reductase instead of a 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase. Mol. Endocrinol. 1993, 7:1569-1578.
130. Abbaszade I.G., Clarke T.R., Park C.H., Payne A.H. The mouse 3 beta-hydroxysteroid dehydrogenase multigene family includes two functionally distinct groups of proteins. Mol. Endocrinol. 1995, 9:1214-1222.
131. de Launoit Y., Zhao H.F., Belanger A., Labrie F., Simard J. Expression of liver-specific member of the 3 beta-hydroxysteroid dehydrogenase family, an isoform possessing an almost exclusive 3-ketosteroid reductase activity. J. Biol. Chem. 1992, 267:4513-4517.
132. Swart P., Swart A.C., Waterman M.R., Estabrook R.W., Mason J.I. Progesterone 16 alpha-hydroxylase activity is catalyzed by human cytochrome P450 17 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 1993, 77:98-102.
133. Tremblay Y., Fleury A., Beaudoin C., Vallee M., Belanger A. Molecular cloning and expression of guinea pig cytochrome P450c17 cDNA (steroid 17 alpha-hydroxylase/17,20 lyase): tissue distribution, regulation, and substrate specificity of the expressed enzyme. DNA Cell. Biol. 1994, 13:1199-1212.
134. Auchus R.J., Lee T.C., Miller W.L. Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J. Biol. Chem. 1998, 273:3158-3165.
135. Nakajin S., Shively J.E., Yuan P.M., Hall P.F. Microsomal cytochrome P-450 from neonatal pig testis: two enzymatic activities (17 alpha-hydroxylase and c17,20-lyase) associated with one protein. Biochemistry 1981, 20:4037-4042.
136. Nakajin S., Hall P.F. Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of a C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase). J. Biol. Chem. 1981, 256:3871-3876.
137. Nakajin S., Hall P.F., Onoda M. Testicular microsomal cytochrome P-450 for C21 steroid side chain cleavage. Spectral and binding studies. J. Biol. Chem. 1981, 256:6134-6139.
138. Nakajin S., Shinoda M., Haniu M., Shively J.E., Hall P.F. C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17 alpha-hydroxylase/C17,20-lyase cytochrome P-450. J. Biol. Chem. 1984, 259:3971-3976.
139. Kominami S., Shinzawa K., Takemori S. Purification and some properties of cytochrome P-450 specific for steroid 17 alpha-hydroxylation and C17-C20 bond cleavage from guinea pig adrenal microsomes. Biochem. Biophys. Res. Commun. 1982, 109:916-921.
140. Suhara K., Fujimura Y., Shiroo M., Katagiri M. Multiple catalytic properties of the purified and reconstituted cytochrome P-450 (P-450sccII) system of pig testis microsomes. J. Biol. Chem. 1984, 259:8729-8736.
141. Zuber M.X., Simpson E.R., Waterman M.R. Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science 1986, 234:1258-1261.
142. Lin D., Harikrishna J.A., Moore C.C., Jones K.L., Miller W.L. Missense mutation serine 106-proline causes 17 alpha-hydroxylase deficiency. J. Biol. Chem. 1991, 266:15992-15998.
143. Omura T., Sanders E., Estabrook R.W., Cooper D.Y., Rosenthal O. Isolation from adrenal cortex of a nonheme iron protein and a flavoprotein as a TPNH-cytochrome P-450 reductase. Arch. Biochem. Biophys. 1966, 117:660-673.
144. Hochberg R.B., Ladany S., Lieberman S. Conversion of a C-20-deoxy-C21, steroid, 5-pregnen-3beta-ol, into testosterone by rat testicular microsomes. J. Biol. Chem. 1976, 251:3320-3325.
145. Onoda M., Haniu M., Yanagibashi K., Sweet F., Shively J.E., Hall P.F. Affinity alkylation of the active site of C21 steroid side-chain cleavage cytochrome P-450 from neonatal porcine testis: a unique cysteine residue alkylated by 17-(bromoacetoxy)progesterone. Biochemistry 1987, 26:657-662.
146. Miller W.L. Androgen biosynthesis from cholesterol to DHEA. Mol. Cell. Endocrinol. 2002, 198:7-14.
147. Oshima H., Ochiai K. On testicular 17-hydroxysteroid oxidoreductase product activation of testosterone formation from androstenedione in vitro. Biochim. Biophys. Acta. 1973, 306:227-236.
148. Hall P.F. Testicular steroid synthesis: organization and regulation. The Physiology of Reproduction 1988, Vol. 1:975-998. Raven Press, New York. E. Knobil, J.D. Neill (Eds.).
149. Yoshinaga-Hirabayashi T., Ishimura K., Fujita H., Inano H., Ishii-Ohba H., Tamaoki B. Immunocytochemical localization of 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD), and its relation to the ultrastructure of steroidogenic cells in immature and mature rat ovaries. Arch. Histol. Jpn. 1987, 50:545-556.
150. Martel C., Rheaume E., Takahashi M., Trudel C., Couet J., Luu-The V., Simard J., Labrie F. Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J. Steroid Biochem. Mol. Biol. 1992, 41:597-603.
151. Wu L., Einstein M., Geissler W.M., Chan H.K., Elliston K.O., Andersson S. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J. Biol. Chem. 1993, 268:12964-12969.
152. Geissler W.M., Davis D.L., Wu L., Bradshaw K.D., Patel S., Mendonca B.B., Elliston K.O., Wilson J.D., Russell D.W., Andersson S. Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat. Genet. 1994, 7:34-39.
153. Ademola Akesode F., Meyer W.J., Migeon C.J. Male pseudohermaphroditism with gynaecomastia due to testicular 17-ketosteroid reductase deficiency. Clin. Endocrinol. (Oxf). 1977, 7:443-452.
154. Wright W.W., Frankel A.I. Endogenous androgen concentrations in nuclei isolated from seminiferous tubules of mature rat testes. J. Steroid Biochem. 1979, 10:633-640.
155. Russell D.W., Wilson J.D. Steroid 5 alpha-reductase: two genes/two enzymes. Annu. Rev. Biochem. 1994, 63:25-61.
156. Matsumoto K., Yamada M. 5-Reduction of testosterone in vitro by rat seminiferous tubules and whole testes at different stages of development. Endocrinology 1973, 93:253-255.
157. Corpechot C., Baulieu E.E., Robel P. Testosterone, dihydrotestosterone and androstanediols in plasma, testes and prostates of rats during development. Acta. Endocrinol. (Copenh). 1981, 96:127-135.
158. Van der Molen H.J., Grootegoed J., de Greef-Bijeveld M., Rommerts F.F., van der Vuuse G. Distribution of steroids, steroid production and steroid metabolizing enzymes in rat testis. Hormonal Regulation of Spermatogenesis 1975, 3-23. Plenum Press, New York. F. French, V. Hansson, E.M. Ritzen, S. Nayfey (Eds.).
159. Sheffield J.W., O'Shaughnessy P.J. Testicular steroid metabolism during development in the normal and hypogonadal mouse. J. Endocrinol. 1999, 119:257-264.
160. Ficher M., Steinberger E. In vitro progesterone metabolism by rat testicular tissue at different stages of development. Acta. Endocrinol. (Copenh). 1971, 68:285-292.
161. Chase D.J., Payne A.H. Changes in distribution and androgen production of Leydig cells of two populations during sexual maturation in the rat. Endocrinology 1983, 112:29-34.
162. Tsujimura T., Matsumoto K. Progesterone metabolism in vitro by mouse testes at different stages of development. Endocrinology 1974, 94:288-290.
163. Chase D.J., Payne A.H. Changes in Leydig cell function during sexual maturation in the mouse. Biol. Reprod. 1983, 29:1194-1200.
164. Watkins W.J., Goldring C.E., Gower D.B. Properties of 4-ene-5 alpha-reductase and studies on its solubilization from porcine testicular microsomes. J. Steroid Biochem. 1988, 29:325-331.
165. Anderson R.A., Wallace A.M., Wu F.C. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. J. Clin. Endocrinol. Metab. 1996, 81:902-908.
166. O'Donnell L., Stanton P.G., Wreford N.G., Robertson D.M., McLachlan R.I. Inhibition of 5 alpha-reductase activity impairs the testosterone-dependent restoration of spermiogenesis in adult rats. Endocrinology 1996, 137:2703-2710.
167. O'Donnell L., Pratis K., Stanton P.G., Robertson D.M., McLachlan R.I. Testosterone-dependent restoration of spermatogenesis in adult rats is impaired by a 5alpha-reductase inhibitor. J. Androl. 1999, 20:109-117.
168. Thigpen A.E., Cala K.M., Russell D.W. Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes. J. Biol. Chem. 1993, 268:17404-17412.
169. Normington K., Russell D.W. Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions. J. Biol. Chem. 1992, 267:19548-19554.
170. Lopez-Solache I., Luu-The V., Seralini G.E., Labrie F. Heterogeneity of rat type I 5 alpha-reductase cDNA: cloning, expression and regulation by pituitary implants and dihydrotestosterone. Biochim. Biophys. Acta. 1996, 1305:139-144.
171. Horton R., Pasupuletti V., Antonipillai I. Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I. Endocrinology 1993, 133:447-451.
172. Antonipillai I., Wahe M., Yamamoto J., Horton R. Activin and inhibin have opposite effects on steroid 5 alpha-reductase activity in genital skin fibroblasts. Mol. Cell. Endocrinol. 1995, 107:99-104.
173. Pratis K., O'Donnell L., Ooi G.T., Stanton P.G., McLachlan R.I., Robertson D.M. Differential regulation of rat testicular 5alpha-reductase type 1 and 2 isoforms by testosterone and FSH. J. Endocrinol. 2003, 176:393-403.
174. Viger R.S., Robaire B. Steady state steroid 5 alpha-reductase messenger ribonucleic acid levels and immunocytochemical localization of the type 1 protein in the rat testis during postnatal development. Endocrinology 1995, 136:5409-5415.
175. Thigpen A.E., Silver R.I., Guileyardo J.M., Casey M.L., McConnell J.D., Russell D.W. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J. Clin. Invest. 1993, 92:903-910.
176. Reyes E.M., Camacho-Arroyo I., Nava G., Cerbon M.A. Differential methylation in steroid 5 alpha-reductase isozyme genes in epididymis, testis, and liver of the adult rat. J. Androl. 1997, 18:372-377.
177. Killian J., Pratis K., Clifton R.J., Stanton P.G., Robertson D.M., O'Donnell L. 5 alpha-reductase isoenzymes 1 and 2 in the rat testis during postnatal development. Biol. Reprod. 2003, 68:1711-1718.
178. Frost P.G., Reed M.J., James V.H. The aromatization of androstenedione by human adipose and liver tissue. J. Steroid Biochem. 1980, 13:1427-1431.
179. Frieden E.H., Patkin J.K., Mills M. Effects of follicle stimulating hormone (FSH) upon steroid aromatization in vitro. Proc. Soc. Exp. Biol. Med. 1968, 129:606-609.
180. Ryan K.J., Naftolin F., Reddy V., Flores F., Petro Z. Estrogen formation in the brain. Am. J. Obstet. Gynecol. 1972, 114:454-460.
181. Gray S.A., Mannan M.A., O'Shaughnessy P.J. Development of cytochrome P450 aromatase mRNA levels and enzyme activity in ovaries of normal and hypogonadal (hpg) mice. J. Mol. Endocrinol. 1995, 14:295-301.
182. Hinshelwood M.M., Corbin C.J., Tsang P.C., Simpson E.R. Isolation and characterization of a complementary deoxyribonucleic acid insert encoding bovine aromatase cytochrome P450. Endocrinology 1993, 133:1971-1977.
183. Terashima M., Toda K., Kawamoto T., Kuribayashi I., Ogawa Y., Maeda T., Shizuta Y. Isolation of a full-length cDNA encoding mouse aromatase P450. Arch. Biochem. Biophys. 1991, 285:231-237.
184. Means G.D., Mahendroo M.S., Corbin C.J., Mathis J.M., Powell F.E., Mendelson C.R., Simpson E.R. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J. Biol. Chem. 1989, 264:19385-19391.
185. Sebastian S., Bulun S.E. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. J. Clin. Endocrinol. Metab. 2001, 86:4600-4602.
186. Toda K., Terashima M., Kawamoto T., Sumimoto H., Yokoyama Y., Kuribayashi I., Mitsuuchi Y., Maeda T., Yamamoto Y., Sagara Y., et al. Structural and functional characterization of human aromatase P-450 gene. Eur. J. Biochem. 1990, 193:559-565.
187. Means G.D., Kilgore M.W., Mahendroo M.S., Mendelson C.R., Simpson E.R. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol. Endocrinol. 1991, 5:2005-2013.
188. Mahendroo M.S., Means G.D., Mendelson C.R., Simpson E.R. Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J. Biol. Chem. 1991, 266:11276-11281.
189. Toda K., Shizuta Y. Molecular cloning of a cDNA showing alternative splicing of the 5′-untranslated sequence of mRNA for human aromatase P-450. Eur. J. Biochem. 1993, 213:383-389.
190. Harada N., Yamada K., Saito K., Kibe N., Dohmae S., Takagi Y. Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem. Biophys. Res. Commun. 1990, 166:365-372.
191. Pierrepoint C.G., Griffiths K., Grant J.K., Stewart J.S. Neutral steroid sulphation and oestrogen biosynthesis in vitro by a feminizing Leydig cell tumour of the testis. J. Endocrinol. 1966, 35:409-417.
192. Valladares L.E., Payne A.H. Acute stimulation of aromatization in Leydig cells by human chorionic gonadotropin in vitro. Proc. Natl. Acad. Sci. U S A 1979, 76:4460-4463.
193. Raeside J.I., Lobb D.K. Metabolism of androstenedione by Sertoli cell enriched preparations and purified Leydig cells from boar testes in relation to estrogen formation. J. Steroid Biochem. 1984, 20:1267-1272.
194. Raeside J.I., Renaud R.L. Estrogen and androgen production by purified Leydig cells of mature boars. Biol. Reprod. 1983, 28:727-733.
195. Dorrington J.H., Fritz I.B., Armstrong D.T. Control of testicular estrogen synthesis. Biol. Reprod. 1978, 18:55-64.
196. Nitta H., Bunick D., Hess R.A., Janulis L., Newton S.C., Millette C.F., Osawa Y., Shizuta Y., Toda K., Bahr J.M. Germ cells of the mouse testis express P450 aromatase. Endocrinology 1993, 132:1396-1401.
197. Rommerts F.F., de Jong F.H., Brinkmann A.O., van der Molen H.J. Development and cellular localization of rat testicular aromatase activity. J. Reprod. Fertil. 1982, 65:281-288.
198. Eisenhauer K.M., McCue P.M., Nayden D.K., Osawa Y., Roser J.F. Localization of aromatase in equine Leydig cells. Domest. Anim. Endocrinol. 1994, 11:291-298.
199. Almadhidi J., Seralini G.E., Fresnel J., Silberzahn P., Gaillard J.L. Immunohistochemical localization of cytochrome P450 aromatase in equine gonads. J. Histochem. Cytochem. 1995, 43:571-577.
200. Payne A.H., Kelch R.P., Musich S.S., Halpern M.E. Intratesticular site of aromatization in the human. J. Clin. Endocrinol. Metab. 1976, 42:1081-1087.
201. Raeside J.I. Seasonal changes in the concentration of estrogens and testosterone in the plasma of the stallion. Anim. Reprod. Sci. 1978, 1:205-212.
202. Carreau S., Genissel C., Bilinska B., Levallet J. Sources of oestrogen in the testis and reproductive tract of the male. Int. J. Androl. 1999, 22:211-223.
203. Carreau S., Lambard S., Delalande C., Denis-Galeraud I., Bilinska B., Bourguiba S. Aromatase expression and role of estrogens in male gonad: a review. Reprod. Biol. Endocrinol. 2003, 1:35.
204. Carreau S., Bourguiba S., Lambard S., Galeraud-Denis I., Genissel C., Levallet J. Reproductive system: aromatase and estrogens. Mol. Cell. Endocrinol. 2002, 193:137-143.
205. Levallet J., Bilinska B., Mittre H., Genissel C., Fresnel J., Carreau S. Expression and immunolocalization of functional cytochrome P450 aromatase in mature rat testicular cells. Biol. Reprod. 1998, 58:919-926.
206. Janulis L., Bahr J.M., Hess R.A., Janssen S., Osawa Y., Bunick D. Rat testicular germ cells and epididymal sperm contain active P450 aromatase. J. Androl. 1998, 19:65-71.
207. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 1997, 337:91-95.
208. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 1995, 80:3689-3698.
209. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994, 331:1056-1061.
210. Robertson K.M., O'Donnell L., Jones M.E., Meachem S.J., Boon W.C., Fisher C.R., Graves K.H., McLachlan R.I., Simpson E.R. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc. Natl. Acad. Sci. U S A 1999, 96:7986-7991.
211. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 1999, 20:358-417.
212. Simpson E.R., Boyd G.S. The cholesterol side-chain cleavage system of the adrenal cortex: a mixed-function oxidase. Biochem. Biophys. Res. Commun. 1966, 24:10-17.
213. Simpson E.R., Boyd G.S. The cholesterol side-chain cleavage system of bovine adrenal cortex. Eur. J. Biochem. 1967, 2:275-285.
214. Hanukoglu I., Hanukoglu Z. Stoichiometry of mitochondrial cytochromes P-450, adrenodoxin and adrenodoxin reductase in adrenal cortex and corpus luteum. Implications for membrane organization and gene regulation. Eur. J. Biochem. 1986, 157:27-31.
215. Liscum L., Dahl N.K. Intracellular cholesterol transport. J. Lipid Res. 1992, 33:1239-1254.
216. Stocco D.M., Clark B.J. Regulation of the acute production of steroids in steroidogenic cells. Endocr. Rev. 1996, 17:221-244.
217. Scallen T.J., Pastuszyn A., Noland B.J., Chanderbhan R., Kharroubi A., Vahouny G.V. Sterol carrier and lipid transfer proteins. Chem. Phys. Lipids 1985, 38:239-261.
218. Pedersen R.C., Brownie A.C. The mechanism of action of adrenocorticotropic hormone on cholesterol metabolism in the adrenal cortex. Biochemical Actions of Hormones 1986, Vol. 13:130-166. Academic Press, New York. G. Litwack (Ed.).
219. van Meer G. Lipid traffic in animal cells. Annu. Rev. Cell. Biol. 1989, 5:247-275.
220. Schroeder F., Jefferson J.R., Kier A.B., Knittel J., Scallen T.J., Wood W.G., Hapala I. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc. Soc. Exp. Biol. Med. 1991, 196:235-252.
221. Zhang M., Liu P., Dwyer N.K., Christenson L.K., Fujimoto T., Martinez F., Comly M., Hanover J.A., Blanchette-Mackie E.J., Strauss J.F. MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J. Biol. Chem. 2002, 277:33300-33310.
222. Kishida T., Kostetskii I., Zhang Z., Martinez F., Liu P., Walkley S.U., Dwyer N.K., Blanchette-Mackie E.J., Radice G.L., Strauss J.F. Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism. J. Biol. Chem. 2004, 279:19276-19285.
223. Garren L.D., Gill G.N., Masui H., Walton G.M. On the mechanism of action of ACTH. Recent Prog. Horm. Res. 1971, 27:433-478.
224. Brownie A.C., Simpson E.R., Jefcoate C.R., Boyd G.S., Orme-Johnson W.H., Beinert H. Effect of ACTH on cholesterol side-chain cleavage in rat adrenal mitochondria. Biochem. Biophys. Res. Commun. 1972, 46:483-490.
225. Brownie A.C., Alfano J., Jefcoate C.R., Orme-Johnson W., Beinert H., Simpson E.R. Effect of ACTH on adrenal mitochondrial cytochrome P-450 in the rat. Ann. N Y Acad. Sci. 1973, 212:344-360.
226. Simpson E.R., McCarthy J.L., Peterson J.A. Evidence that the cycloheximide-sensitive site of adrenocorticotropic hormone action is in the mitochondrion. Changes in pregnenolone formation, cholesterol content, and the electron paramagnetic resonance spectra of cytochrome P-450. J. Biol. Chem. 1978, 253:3135-3139.
227. Crivello J.F., Jefcoate C.R. Intracellular movement of cholesterol in rat adrenal cells. Kinetics and effects of inhibitors. J. Biol. Chem. 1980, 255:8144-8151.
228. Mori M., Marsh J.M. The site of luteinizing hormone stimulation of steroidogenesis in mitochondria of the rat corpus luteum. J. Biol. Chem. 1982, 257:6178-6183.
229. Privalle C.T., Crivello J.F., Jefcoate C.R. Regulation of intramitochondrial cholesterol transfer to side-chain cleavage cytochrome P-450 in rat adrenal gland. Proc. Natl. Acad. Sci. U S A 1983, 80:702-706.
230. Jefcoate C.R., DiBartolomeis M.J., Williams C.A., McNamara B.C. ACTH regulation of cholesterol movement in isolated adrenal cells. J. Steroid Biochem. 1987, 27:721-729.
231. Lambeth J.D., Kitchen S.E., Farooqui A.A., Tuckey R., Kamin H. Cytochrome P-450scc-substrate interactions. Studies of binding and catalytic activity using hydroxycholesterols. J. Biol. Chem. 1982, 257:1876-1884.
232. Tuckey R.C., Stevenson P.M. Properties of bovine luteal cytochrome P-450scc incorporated into artificial phospholipid vesicles. Int. J. Biochem. 1984, 16:497-503.
233. Tuckey R.C., Atkinson H.C. Pregnenolone synthesis from cholesterol and hydroxycholesterols by mitochondria from ovaries following the stimulation of immature rats with pregnant mare's serum gonadotropin and human choriogonadotropin. Eur. J. Biochem. 1989, 186:255-259.
234. Tuckey R.C. Cholesterol side-chain cleavage by mitochondria from the human placenta. Studies using hydroxycholesterols as substrates. J. Steroid Biochem. Mol. Biol. 1992, 42:883-890.
235. Phillips M.C., Johnson W.J., Rothblat G.H. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 1987, 906:223-276.
236. Rennert H.Y.J.C., Strauss J.F. Intracellular cholesterol dynamics in steroidogenic cells. A contemporary view. The Ovary 1993, 147-164. Raven Press, Orlando, FL. E.Y. Adashi, P.C. Leung (Eds.).
237. Ferguson J.J. Puromycin and adrenal responsiveness to adrenocorticotropic hormone. Biochim. Biophys. Acta. 1962, 57:616-617.
238. Ferguson J.J. Protein synthesis and adrenocorticotropin responsiveness. J. Biol. Chem. 1963, 238:2754-2759.
239. Garren L.D., Ney R.L., Davis W.W. Studies on the role of protein synthesis in the regulation of corticosterone production by adrenocorticotropic hormone in vivo. Proc. Natl. Acad. Sci. U S A 1965, 53:1443-1450.
240. Garren L.D., Davis W.W., Crocco R.M., Ney R.L. Puromycin analogs: action of adrenocorticotropic hormone and the role of glycogen. Science 1966, 152:1386-1388.
241. Davis W.W., Garren L.D. On the mechanism of action of adrenocorticotropic hormone. The inhibitory site of cycloheximide in the pathway of steroid biosynthesis. J. Biol. Chem. 1968, 243:5153-5157.
242. Garren L.D. The mechanism of action of adrenocorticotropic hormone. Vitam. Horm. 1968, 26:119-145.
243. Davis W.W., Garren L.D. Evidence for the stimulation by adenocorticotropic hormone of the conversion of cholesterol esters to cholesterol in the adrenal, in vivo. Biochem. Biophys. Res. Commun. 1966, 22:805-810.
244. Farese R.V. Adrenocorticotrophin-induced changes in the steroidogenic activity of adrenal cell-free preparations. Biochemistry 1967, 6:2052-2065.
245. Cooke B.A., Janszen F.H., Clotscher W.F., van der Molen H.J. Effect of protein-synthesis inhibitors on testosterone production in rat testis interstitial tissue and Leydig-cell preparations. Biochem. J. 1975, 150:413-418.
246. Paul D.P., Gallant S., Orme-Johnson N.R., Orme-Johnson W.H., Brownie A.C. Temperature dependence of cholesterol binding to cytochrome P-450scc of the rat adrenal. Effect of adrenocorticotropic hormone and cycloheximide. J. Biol. Chem. 1976, 251:7120-7126.
247. Farese R.V., Prudente W.J. On the requirement for protein synthesis during corticotropin-induced stimulation of cholesterol side chain cleavage in rat adrenal mitochondrial and solubilized desmolase preparations. Biochim. Biophys. Acta. 1977, 496:567-570.
248. Crivello J.F., Jefcoate C.R. Mechanisms of corticotropin action in rat adrenal cells. I. The effects of inhibitors of protein synthesis and of microfilament formation on corticosterone synthesis. Biochim. Biophys. Acta. 1978, 542:315-329.
249. Toaff M.E., Strauss J.F., Flickinger G.L., Shattil S.J. Relationship of cholesterol supply to luteal mitochondrial steroid synthesis. J. Biol. Chem. 1979, 254:3977-3982.
250. Solano A.R., Neher R., Podesta E.J. Rat adrenal cycloheximide-sensitive factors and phospholipids in the control of acute steroidogenesis. J. Steroid Biochem. 1984, 21:111-116.
251. Stevens V.L., Xu T., Lambeth J.D. Cholesterol trafficking in steroidogenic cells. Reversible cycloheximide-dependent accumulation of cholesterol in a pre-steroidogenic pool. Eur. J. Biochem. 1993, 216:557-563.
252. Janszen F.H., Cooke B.A., van Driel M.J., van der Molen H.J. LH induction of a specific protein (LH-IP) in rat testis Leydig cells. FEBS Lett. 1976, 71:269-272.
253. Janszen F.H., Cooke B.A., van der Molen H.J. Specific protein synthesis in isolated rat testis Leydig cells. Influence of luteinizing hormone and cycloheximide. Biochem. J. 1977, 162:341-346.
254. Krueger R.J., Orme-Johnson N.R. Acute adrenocorticotropic hormone stimulation of adrenal corticosteroidogenesis. Discovery of a rapidly induced protein. J. Biol. Chem. 1983, 258:10159-10167.
255. Epstein L.F., Orme-Johnson N.R. Acute action of luteinizing hormone on mouse Leydig cells: accumulation of mitochondrial phosphoproteins and stimulation of testosterone synthesis. Mol. Cell. Endocrinol. 1991, 81:113-126.
256. Epstein L.F., Orme-Johnson N.R. Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J. Biol. Chem. 1991, 266:19739-19745.
257. Pon L.A., Orme-Johnson N.R. Acute stimulation of corpus luteum cells by gonadotrophin or adenosine 3′,5′-monophosphate causes accumulation of a phosphoprotein concurrent with acceleration of steroid synthesis. Endocrinology 1988, 123:1942-1948.
258. Stocco D.M., Sodeman T.C. The 30-kDa mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cells are processed from larger precursors. J. Biol. Chem. 1991, 266:19731-19738.
259. Stocco D.M., Chen W. Presence of identical mitochondrial proteins in unstimulated constitutive steroid-producing R2C rat Leydig tumor and stimulated nonconstitutive steroid-producing MA-10 mouse Leydig tumor cells. Endocrinology 1991, 128:1918-1926.
260. Arthur J.R., Boyd G.S. The effect of inhibitors of protein synthesis on cholesterol side-chain cleavage in the mitochondria of luteinized rat ovaries. Eur. J. Biochem. 1974, 49:117-127.
261. Ohno Y., Yanagibashi K., Yonezawa Y., Ishiwatari S., Matsuba M. A possible role of "steroidogenic factor" in the corticoidogenic response to ACTH; effect of ACTH, cycloheximide and aminoglutethimide on the content of cholesterol in the outer and inner mitochondrial membrane of rat adrenal cortex. Endocrinol. Jpn. 1983, 30:335-338.
262. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev. 1993, 14:222-240.
263. Lacapere J.J., Papadopoulos V. Peripheraltype benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 2003, 68:569-585.
264. Pon L.A., Orme-Johnson N.R. Acute stimulation of steroidogenesis in corpus luteum and adrenal cortex by peptide hormones. Rapid induction of a similar protein in both tissues. J. Biol. Chem. 1986, 261:6594-6599.
265. Pon L.A., Hartigan J.A., Orme-Johnson N.R. Acute ACTH regulation of adrenal corticosteroid biosynthesis. Rapid accumulation of a phosphoprotein. J. Biol. Chem. 1986, 261:13309-13316.
266. Pon L.A., Epstein L.F., Orme-Johnson N.R. Acute cAMP stimulation in Leydig cells: rapid accumulation of a protein similar to that detected in adrenal cortex and corpus luteum. Endocr. Res. 1986, 12:429-446.
267. Alberta J.A., Epstein L.F., Pon L.A., Orme-Johnson N.R. Mitochondrial localization of a phosphoprotein that rapidly accumulates in adrenal cortex cells exposed to adrenocorticotropic hormone or to cAMP. J. Biol. Chem. 1989, 264:2368-2372.
268. Stocco D.M., Kilgore M.W. Induction of mitochondrial proteins in MA-10 Leydig tumour cells with human choriogonadotropin. Biochem. J. 1988, 249:95-103.
269. Stocco D.M., Chaudhary L.R. Evidence for the functional coupling of cyclic AMP in MA-10 mouse Leydig tumour cells. Cell. Signal. 1990, 2:161-170.
270. Stocco D.M. Further evidence that the mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cells are involved in the acute regulation of steroidogenesis. J. Steroid Biochem. Mol. Biol. 1992, 43:319-333.
271. Stocco D.M., Ascoli M. The use of genetic manipulation of MA-10 Leydig tumor cells to demonstrate the role of mitochondrial proteins in the acute regulation of steroidogenesis. Endocrinology 1993, 132:959-967.
272. Stocco D.M., King S., Clark B.J. Differential effects of dimethylsulfoxide on steroidogenesis in mouse MA-10 and rat R2C Leydig tumor cells. Endocrinology 1995, 136:2993-2999.
273. Clark B.J., Wells J., King S.R., Stocco D.M. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 1994, 269:28314-28322.
274. Lin D., Gitelman S.E., Saenger P., Miller W.L. Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. J. Clin. Invest. 1991, 88:1955-1962.
275. Lin D., Chang Y.J., Strauss J.F., Miller W.L. The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics 1993, 18:643-650.
276. Lin D., Sugawara T., Strauss J.F., Clark B.J., Stocco D.M., Saenger P., Rogol A., Miller W.L. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995, 267:1828-1831.
277. Bose H.S., Sugawara T., Strauss J.F., Miller W.L. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N. Engl. J. Med. 1996, 335:1870-1878.
278. Stocco D.M. Clinical disorders associated with abnormal cholesterol transport: mutations in the steroidogenic acute regulatory protein. Mol. Cell. Endocrinol. 2002, 191:19-25.
279. Caron K.M., Soo S.C., Wetsel W.C., Stocco D.M., Clark B.J., Parker K.L. Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc. Natl. Acad. Sci. U S A 1997, 94:11540-11545.
280. Pedersen R.C., Brownie A.C. Cholesterol side-chain cleavage in the rat adrenal cortex: isolation of a cycloheximide-sensitive activator peptide. Proc. Natl. Acad. Sci. U S A 1983, 80:1882-1886.
281. Pedersen R.C. Polypeptide activators of cholesterol side-chain cleavage. Endocr. Res. 1984, 10:533-561.
282. Pedersen R.C., Brownie A.C. Steroidogenesis-activator polypeptide isolated from a rat Leydig cell tumor. Science 1987, 236:188-190.
283. Pedersen R.C. Steroidogenesis activator polypeptide (SAP) in the rat ovary and testis. J. Steroid Biochem. 1987, 27:731-735.
284. Mertz L.M., Pedersen R.C. The kinetics of steroidogenesis activator polypeptide in the rat adrenal cortex. Effects of adrenocorticotropin, cyclic adenosine 3′:5′-monophosphate, cycloheximide, and circadian rhythm. J. Biol. Chem. 1989, 264:15274-15279.
285. Frustaci J., Mertz L.M., Pedersen R.C. Steroidogenesis activator polypeptide (SAP) in the guinea pig adrenal cortex. Mol. Cell. Endocrinol. 1989, 64:137-143.
286. Mertz L.M., Pedersen R.C. Steroidogenesis activator polypeptide may be a product of glucose regulated protein 78 (GRP78). Endocr. Res. 1989, 15:101-115.
287. Li X.A., Warren D.W., Gregoire J., Pedersen R.C., Lee A.S. The rat 78,000 dalton glucose-regulated protein (GRP78) as a precursor for the rat steroidogenesis-activator polypeptide (SAP): the SAP coding sequence is homologous with the terminal end of GRP78. Mol. Endocrinol. 1989, 3:1944-1952.
288. Woods M.J., Zisterer D.M., Williams D.C. Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver. Biochem. Pharmacol. 1996, 51:1283-1292.
289. Garnier M., Boujrad N., Oke B.O., Brown A.S., Riond J., Ferrara P., Shoyab M., Suarez-Quian C.A., Papadopoulos V. Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology 1993, 132:444-458.
290. Hardwick M., Fertikh D., Culty M., Li H., Vidic B., Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 1999, 59:831-842.
291. Verma A., Snyder S.H. Peripheral type benzodiazepine receptors. Annu. Rev. Pharmacol. Toxicol. 1989, 29:307-322.
292. Parola A.L., Yamamura H.I., Laird H.E. Peripheral-type benzodiazepine receptors. Life Sci. 1993, 52:1329-1342.
293. Yanagibashi K., Ohno Y., Kawamura M., Hall P.F. The regulation of intracellular transport of cholesterol in bovine adrenal cells: purification of a novel protein. Endocrinology 1988, 123:2075-2082.
294. Besman M.J., Yanagibashi K., Lee T.D., Kawamura M., Hall P.F., Shively J.E. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc. Natl. Acad. Sci. U S A 1989, 86:4897-4901.
295. Holloway C.D., Kenyon C.J., Dowie L.J., Corrie J.E., Gray C.E., Fraser R. Effect of the benzodiazepines diazepam, des-N-methyldiazepam and midazolam on corticosteroid biosynthesis in bovine adrenocortical cells in vitro; location of site of action. J. Steroid Biochem. 1989, 33:219-225.
296. Amsterdam A., Suh B.S. An inducible functional peripheral benzodiazepine receptor in mitochondria of steroidogenic granulosa cells. Endocrinology 1991, 129:503-510.
297. Yanagibashi K., Ohno Y., Nakamichi N., Matsui T., Hayashida K., Takamura M., Yamada K., Tou S., Kawamura M. Peripheral-type benzodiazepine receptors are involved in the regulation of cholesterol side chain cleavage in adrenocortical mitochondria. J. Biochem. (Tokyo) 1989, 106:1026-1029.
298. Papadopoulos V., Mukhin A.G., Costa E., Krueger K.E. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 1990, 265:3772-3779.
299. Papadopoulos V., Berkovich A., Krueger K.E., Costa E., Guidotti A. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology 1991, 129:1481-1488.
300. Cavallaro S., Korneyev A., Guidotti A., Costa E. Diazepam-binding inhibitor (DBI)-processing products, acting at the mitochondrial DBI receptor, mediate adrenocorticotropic hormone-induced steroidogenesis in rat adrenal gland. Proc. Natl. Acad. Sci. U S A 1992, 89:10598-10602.
301. Barnea E.R., Fares F., Gavish M. Modulatory action of benzodiazepines on human term placental steroidogenesis in vitro. Mol. Cell. Endocrinol. 1989, 64:155-159.
302. Mukhin A.G., Papadopoulos V., Costa E., Krueger K.E. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc. Natl. Acad. Sci. U S A 1989, 86:9813-9816.
303. Boujrad N., Hudson J.R., Papadopoulos V. Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor. Proc. Natl. Acad. Sci. U S A 1993, 90:5728-5731.
304. Garnier M., Boujrad N., Ogwuegbu S.O., Hudson J.R., Papadopoulos V. The polypeptide diazepambinding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 1994, 269:22105-22112.
305. Krueger K.E., Papadopoulos V. Peripheraltype benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J. Biol. Chem. 1990, 265:15015-15022.
306. Anholt R.R., De Souza E.B., Kuhar M.J., Snyder S.H. Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. Eur. J. Pharmacol. 1985, 110:41-46.
307. Massotti M., Slobodyansky E., Konkel D., Costa E., Guidotti A. Regulation of diazepam binding inhibitor in rat adrenal gland by adrenocorticotropin. Endocrinology 1991, 129:591-596.
308. Cavallaro S., Pani L., Guidotti A., Costa E. ACTH-induced mitochondrial DBI receptor (MDR) and diazepam binding inhibitor (DBI) expression in adrenals of hypophysectomized rats is not cause-effect related to its immediate steroidogenic action. Life Sci. 1993, 53:1137-1147.
309. Brown A.S., Hall P.F., Shoyab M., Papadopoulos V. Endozepine/diazepam binding inhibitor in adrenocortical and Leydig cell lines: absence of hormonal regulation. Mol. Cell. Endocrinol. 1992, 83:1-9.
310. Papadopoulos V., Nowzari F.B., Krueger K.E. Hormone-stimulated steroidogenesis is coupled to mitochondrial benzodiazepine receptors. Tropic hormone action on steroid biosynthesis is inhibited by flunitrazepam. J. Biol. Chem. 1991, 266:3682-3687.
311. Boujrad N., Gaillard J.L., Garnier M., Papadopoulos V. Acute action of choriogonadotropin on Leydig tumor cells: induction of a higher affinity benzodiazepine-binding site related to steroid biosynthesis. Endocrinology 1994, 135:1576-1583.
312. Papadopoulos V., Brown A.S. Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J. Steroid Biochem. Mol. Biol. 1995, 53:103-110.
313. Papadopoulos V., Boujrad N., Ikonomovic M.D., Ferrara P., Vidic B. Topography of the Leydig cell mitochondrial peripheral-type benzodiazepine receptor. Mol. Cell. Endocrinol. 1994, 104:R5-R9.
314. Papadopoulos V., Amri H., Li H., Boujrad N., Vidic B., Garnier M. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 1997, 272:32129-32135.
315. Boujrad N., Vidic B., Papadopoulos V. Acute action of choriogonadotropin on Leydig tumor cells: changes in the topography of the mitochondrial peripheral-type benzodiazepine receptor. Endocrinology 1996, 137:5727-5730.
316. Niswender G.D. Molecular control of luteal secretion of progesterone. Reproduction 2002, 123:333-339.
317. Lazzarini R., Malucelli B.E., Palermo-Neto J. Reduction of acute inflammation in rats by diazepam: role of peripheral benzodiazepine receptors and corticosterone. Immunopharmacol. Immunotoxicol. 2001, 23:253-265.
318. Lazzarini R., Malucelli B.E., Muscara M.N., de Nucci G., Palermo-Neto J. Reduction of inflammation in rats by diazepam: tolerance development. Life Sci. 2003, 72:2361-2368.
319. Marc V., Morselli P.L. Effect of diazepam on plasma corticosterone levels in the rat. J. Pharm. Pharmacol. 1969, 21:784-786.
320. Weizman R., Leschiner S., Schlegel W., Gavish M. Peripheral-type benzodiazepine receptor ligands and serum steroid hormones. Brain Res. 1997, 772:203-208.
321. Stocco D.M. A StAR search: implications in controlling steroidogenesis. Biol. Reprod. 1997, 56:328-336.
322. Miller W.L. Congenital lipoid adrenal hyperplasia: the human gene knockout for the steroidogenic acute regulatory protein. J. Mol. Endocrinol. 1997, 19:227-240.
323. Stocco D.M. Steroidogenic acute regulatory protein. Vitam. Horm. 1999, 55:399-441.
324. Miller W.L., Strauss J.F. Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR. J. Steroid Biochem. Mol. Biol. 1999, 69:131-141.
325. Orly J., Stocco D.M. The role of the steroidogenic acute regulatory
326. Christenson L.K., Strauss J.F. Steroidogenic acute regulatory protein (StAR) and the intramitochondrial translocation of cholesterol. Biochim. Biophys. Acta. 2000, 1529:175-187.
327. Stocco D. StAR protein and the regulation of steroid hormone biosynthesis. Annu. Rev. Physiol. 2001, 63:193-213.
328. Stocco D.M. Tracking the role of a StAR in the sky of the new millennium. Mol. Endocrinol. 2001, 15:1245-1254.
329. Christenson L.K., Strauss J.F. Steroidogenic acute regulatory protein: an update on its regulation and mechanism of action. Arch. Med. Res. 2001, 32:576-586.
330. Strauss J.F., Kishida T., Christenson L.K., Fujimoto T., Hiroi H. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol. Cell. Endocrinol. 2003, 202:59-65.
331. Clark B.J., Soo S.C., Caron K.M., Ikeda Y., Parker K.L., Stocco D.M. Hormonal and developmental regulation of the steroidogenic acute regulatory protein. Mol. Endocrinol. 1995, 9:1346-1355.
332. Clark B.J., Stocco D.M. Expression of the steroidogenic acute regulatory (StAR) protein: a novel LH-induced mitochondrial protein required for the acute regulation of steroidogenesis in mouse Leydig tumor cells. Endocr. Res. 1995, 21:243-257.
333. Sugawara T., Holt J.A., Driscoll D., Strauss J.F., Lin D., Miller W.L., Patterson D., Clancy K.P., Hart I.M., Clark B.J., Stocco D.M. Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc. Natl. Acad. Sci. U S A 1995, 92:4778-4782.
334. Clark B.J., Combs R., Hales K.H., Hales D.B., Stocco D.M. Inhibition of transcription affects synthesis of steroidogenic acute regulatory protein and steroidogenesis in MA-10 mouse Leydig tumor cells. Endocrinology 1997, 138:4893-4901.
335. Nalbant D., Williams S.C., Stocco D.M., Khan S.A. Luteinizing hormone-dependent gene regulation in Leydig cells may be mediated by CCAAT/enhancer-binding protein-beta. Endocrinology 1998, 139:272-279.
336. Luo L., Chen H., Stocco D.M., Zirkin B.R. Leydig cell protein synthesis and steroidogenesis in response to acute stimulation by luteinizing hormone in rats. Biol. Reprod. 1998, 59:263-270.
337. Akingbemi B.T., Ge R., Rosenfeld C.S., Newton L.G., Hardy D.O., Catterall J.F., Lubahn D.B., Korach K.S., Hardy M.P. Estrogen receptor-alpha gene deficiency enhances androgen biosynthesis in the mouse Leydig cell. Endocrinology 2003, 144:84-93.
338. Price C.A., Cooke G.M., Sanford L.M. Influence of season and low-level oestradiol immunoneutralization on episodic LH and testosterone secretion and testicular steroidogenic enzymes and steroidogenic acute regulatory protein in the adult ram. J. Reprod. Fertil. 2000, 118:251-262.
339. Kim Y.C., Ariyoshi N., Artemenko I., Elliott M.E., Bhattacharyya K.K., Jefcoate C.R. Control of cholesterol access to cytochrome P450scc in rat adrenal cells mediated by regulation of the steroidogenic acute regulatory protein. Steroids 1997, 62:10-20.
340. Lin T., Wang D., Hu J., Stocco D.M. Upregulation of human chorionic gonadotrophin-induced steroidogenic acute regulatory protein by insulin-like growth factor-I in rat Leydig cells. Endocrine 1998, 8:73-78.
341. Ramnath H.I., Peterson S., Michael A.E., Stocco D.M., Cooke B.A. Modulation of steroidogenesis by chloride ions in MA-10 mouse tumor Leydig cells: roles of calcium, protein synthesis, and the steroidogenic acute regulatory protein. Endocrinology 1997, 138:2308-2314.
342. Huang B.M., Stocco D.M., Li P.H., Yang H.Y., Wu C.M., Norman R.L. Corticotropin-releasing hormone stimulates the expression of the steroidogenic acute regulatory protein in MA-10 mouse cells. Biol. Reprod. 1997, 57:547-551.
343. Manna P.R., Pakarinen P., El-Hefnawy T., Huhtaniemi I.T. Functional assessment of the calcium messenger system in cultured mouse Leydig tumor cells: regulation of human chorionic gonadotropin-induced expression of the steroidogenic acute regulatory protein. Endocrinology 1999, 140:1739-1751.
344. Manna P.R., Tena-Sempere M., Huhtaniemi I.T. Molecular mechanisms of thyroid hormone-stimulated steroidogenesis in mouse Leydig tumor cells. Involvement of the steroidogenic acute regulatory (StAR) protein. J. Biol. Chem. 1999, 274:5909-5918.
345. Manna P.R., Kero J., Tena-Sempere M., Pakarinen P., Stocco D.M., Huhtaniemi I.T. Assessment of mechanisms of thyroid hormone action in mouse Leydig cells: regulation of the steroidogenic acute regulatory protein, steroidogenesis, and luteinizing hormone receptor function. Endocrinology 2001, 142:319-331.
346. Manna P.R., Roy P., Clark B.J., Stocco D.M., Huhtaniemi I.T. Interaction of thyroid hormone and steroidogenic acute regulatory (StAR) protein in the regulation of murine Leydig cell steroidogenesis. J. Steroid Biochem. Mol. Biol. 2001, 76:167-177.
347. Lee H.K., Yoo M.S., Choi H.S., Kwon H.B., Soh J. Retinoic acids up-regulate steroidogenic acute regulatory protein gene. Mol. Cell. Endocrinol. 1999, 148:1-10.
348. Nagata Y., Homma H., Matsumoto M., Imai K. Stimulation of steroidogenic acute regulatory protein (StAR) gene expression by D-aspartate in rat Leydig cells. FEBS Lett. 1999, 454:317-320.
349. Kanzaki M., Morris P.L. Growth hormone regulates steroidogenic acute regulatory protein expression and steroidogenesis in Leydig cell progenitors. Endocrinology 1999, 140:1681-1686.
350. Manna P.R., Huhtaniemi I.T., Wang X.J., Eubank D.W., Stocco D.M. Mechanisms of epidermal growth factor signaling: regulation of steroid biosynthesis and the steroidogenic acute regulatory protein in mouse Leydig tumor cells. Biol. Reprod. 2002, 67:1393-1404.
351. Schwarzenbach H., Manna P.R., Stocco D.M., Chakrabarti G., Mukhopadhyay A.K. Stimulatory effect of progesterone on the expression of steroidogenic acute regulatory protein in MA-10 Leydig cells. Biol. Reprod. 2003, 68:1054-1063.
352. Wang X., Walsh L.P., Stocco D.M. The role of arachidonic acid on LH-stimulated steroidogenesis and steroidogenic acute regulatory protein accumulation in MA-10 mouse Leydig tumor cells. Endocrine 1999, 10:7-12.
353. Wang X., Walsh L.P., Reinhart A.J., Stocco D.M. The role of arachidonic acid in steroidogenesis and steroidogenic acute regulatory (StAR) gene and protein expression. J. Biol. Chem. 2000, 275:20204-20209.
354. Wang X.J., Dyson M.T., Mondillo C., Patrignani Z., Pignataro O., Stocco D.M. Interaction between arachidonic acid and cAMP signaling pathways enhances steroidogenesis and StAR gene expression in MA-10 Leydig tumor cells. Mol. Cell. Endocrinol. 2002, 188:55-63.
355. Wang X., Dyson M.T., Jo Y., Stocco D.M. Inhibition of cyclooxygenase-2 activity enhances steroidogenesis and steroidogenic acute regulatory gene expression in MA-10 mouse Leydig cells. Endocrinology 2003, 144:3368-3375.
356. Wang X.J., Dyson M.T., Jo Y., Eubank D.W., Stocco D.M. Involvement of 5-lipoxygenase metabolites of arachidonic acid in cyclic AMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression. J. Steroid Biochem. Mol. Biol. 2003, 85:159-166.
357. Choi Y.S., Stocco D.M., Freeman D.A. Diethylumbelliferyl phosphate inhibits steroidogenesis by interfering with a long-lived factor acting between protein kinase A activation and induction of the steroidogenic acute regulatory protein (StAR). Eur. J. Biochem. 1995, 234:680-685.
358. Bosmann H.B., Hales K.H., Li X., Liu Z., Stocco D.M., Hales D.B. Acute in vivo inhibition of testosterone by endotoxin parallels loss of steroidogenic acute regulatory (StAR) protein in Leydig cells. Endocrinology 1996, 137:4522-4525.
359. Hales K.H., Diemer T., Ginde S., Shankar B.K., Roberts M., Bosmann H.B., Hales D.B. Diametric effects of bacterial endotoxin lipopolysaccharide on adrenal and Leydig cell steroidogenic acute regulatory protein. Endocrinology 2000, 141:4000-4012.
360. Sam A.D., Sharma A.C., Lee L.Y., Hales D.B., Law W.R., Ferguson J.L., Bosmann H.B. Sepsis produces depression of testosterone and steroidogenic acute regulatory (StAR) protein. Shock 1999, 11:298-301.
361. Khanna A., Aten R.F., Behrman H.R. Heat shock protein induction blocks hormone-sensitive steroidogenesis in rat luteal cells. Steroids 1994, 59:4-9.
362. Khanna A., Aten R.F., Behrman H.R. Physiological and pharmacological inhibitors of luteinizing hormone-dependent steroidogenesis induce heat shock protein-70 in rat luteal cells. Endocrinology 1995, 136:1775-1781.
363. Liu Z., Stocco D.M. Heat shock-induced inhibition of acute steroidogenesis in MA-10 cells is associated with inhibition of the synthesis of the steroidogenic acute regulatory protein. Endocrinology 1997, 138:2722-2728.
364. Murphy B.D., Lalli E., Walsh L.P., Liu Z., Soh J., Stocco D.M., Sassone-Corsi P. Heat shock interferes with steroidogenesis by reducing transcription of the steroidogenic acute regulatory protein gene. Mol. Endocrinol. 2001, 15:1255-1263.
365. Lin T., Wang D., Stocco D.M. Interleukin-1 inhibits Leydig cell steroidogenesis without affecting steroidogenic acute regulatory protein messenger ribonucleic acid or protein levels. J. Endocrinol. 1998, 156:461-467.
366. Ogilvie K.M., Held Hales K., Roberts M.E., Hales D.B., Rivier C. The inhibitory effect of intracerebroventricularly injected interleukin 1beta on testosterone secretion in the rat: role of steroidogenic acute regulatory protein. Biol. Reprod. 1999, 60:527-533.
367. Mauduit C., Gasnier F., Rey C., Chauvin M.A., Stocco D.M., Louisot P., Benahmed M. Tumor necrosis factor-alpha inhibits Leydig cell steroidogenesis through a decrease in steroidogenic acute regulatory protein expression. Endocrinology 1998, 139:2863-2868.
368. Budnik L.T., Jahner D., Mukhopadhyay A.K. Inhibitory effects of TNF alpha on mouse tumor Leydig cells: possible role of ceramide in the mechanism of action. Mol. Cell. Endocrinol. 1999, 150:39-46.
369. Morales V., Santana P., Diaz R., Tabraue C., Gallardo G., Lopez Blanco F., Hernandez I., Fanjul L.F., Ruiz de Galarreta C.M. Intratesticular delivery of tumor necrosis factor-alpha and ceramide directly abrogates steroidogenic acute regulatory protein expression and Leydig cell steroidogenesis in adult rats. Endocrinology 2003, 144:4763-4772.
370. Lin T., Hu J., Wang D., Stocco D.M. Interferon-gamma inhibits the steroidogenic acute regulatory protein messenger ribonucleic acid expression and protein levels in primary cultures of rat Leydig cells. Endocrinology 1998, 139:2217-2222.
371. Mauduit C., Goddard I., Besset V., Tabone E., Rey C., Gasnier F., Dacheux F., Benahmed M. Leukemia inhibitory factor antagonizes gonadotropin induced-testosterone synthesis in cultured porcine leydig cells: sites of action. Endocrinology 2001, 142:2509-2520.
372. King S.R., Rommerts F.F., Ford S.L., Hutson J.C., Orly J., Stocco D.M. Ethane dimethane sulfonate and NNN′N′-tetrakis-(2-pyridylmethyl)ethylenediamine inhibit steroidogenic acute regulatory (StAR) protein expression in MA-10 Leydig cells and rat Sertoli cells. Endocr. Res. 1998, 24:469-478.
373. King S.R., Walsh L.P., Stocco D.M. Nigericin inhibits accumulation of the steroidogenic acute regulatory protein but not steroidogenesis. Mol. Cell. Endocrinol. 2000, 166:147-153.
374. Wu C.S., Leu S.F., Yang H.Y., Huang B.M. Melatonin inhibits the expression of steroidogenic acute regulatory protein and steroidogenesis in MA-10 cells. J. Androl. 2001, 22:245-254.
375. Tena-Sempere M., Manna P.R., Zhang F.P., Pinilla L., Gonzalez L.C., Dieguez C., Huhtaniemi I., Aguilar E. Molecular mechanisms of leptin action in adult rat testis: potential targets for leptin-induced inhibition of steroidogenesis and pattern of leptin receptor messenger ribonucleic acid expression. J. Endocrinol. 2001, 170:413-423.
376. Chiao Y.C., Cho W.L., Wang P.S. Inhibition of testosterone production by propylthiouracil in rat Leydig cells. Biol. Reprod. 2002, 67:416-422.
377. Walsh L.P., Kuratko C.N., Stocco D.M. Econazole and miconazole inhibit steroidogenesis and disrupt steroidogenic acute regulatory (StAR) protein expression post-transcriptionally. J. Steroid Biochem. Mol. Biol. 2000, 75:229-236.
378. Kim J.H., Kim H.J., Noh H.S., Roh G.S., Kang S.S., Cho G.J., Park S.K., Lee B.J., Choi W.S. Suppression by ethanol of male reproductive activity. Brain Res. 2003, 989:91-98.
379. Ikeda Y., Lala D.S., Luo X., Kim E., Moisan M.P., Parker K.L. Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol. Endocrinol. 1993, 7:852-860.
380. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490.
381. Shinoda K., Lei H., Yoshii H., Nomura M., Nagano M., Shiba H., Sasaki H., Osawa Y., Ninomiya Y., Niwa O., et al. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev. Dyn. 1995, 204:22-29.
382. Sadovsky Y., Crawford P.A., Woodson K.G., Polish J.A., Clements M.A., Tourtellotte L.M., Simburger K., Milbrandt J. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. U S A 1995, 92:10939-10943.
383. Caron K.M., Ikeda Y., Soo S.C., Stocco D.M., Parker K.L., Clark B.J. Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory protein. Mol. Endocrinol. 1997, 11:138-147.
384. Sugawara T., Kiriakidou M., McAllister J.M., Kallen C.B., Strauss J.F. Multiple steroidogenic factor 1 binding elements in the human steroidogenic acute regulatory protein gene 5′-flanking region are required for maximal promoter activity and cyclic AMP responsiveness. Biochemistry 1997, 36:7249-7255.
385. Sandhoff T.W., Hales D.B., Hales K.H., McLean M.P. Transcriptional regulation of the rat steroidogenic acute regulatory protein gene by steroidogenic factor 1. Endocrinology 1998, 139:4820-4831.
386. Sugawara T., Holt J.A., Kiriakidou M., Strauss J.F. Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene. Biochemistry 1996, 35:9052-9059.
387. Clark B.J., Combs R. Angiotensin II and cyclic adenosine 3′,5′-monophosphate induce human steroidogenic acute regulatory protein transcription through a common steroidogenic factor-1 element. Endocrinology 1999, 140:4390-4398.
388. Wooton-Kee C.R., Clark B.J. Steroidogenic factor-1 influences protein-deoxyribonucleic acid interactions within the cyclic adenosine 3,5-monophosphate-responsive regions of the murine steroidogenic acute regulatory protein gene. Endocrinology 2000, 141:1345-1355.
389. Johnson P.F., Williams S.C. CCAAT/enhancer binding (C/EBP) proteins. Liver Gene Expression 1994, 231-258. R. G. Landes Co., New York. F. Tronche, M. Yaniv (Eds.).
390. Lekstrom-Himes J., Xanthopoulos K.G. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 1998, 273:28545-28548.
391. Sirois J., Richards J.S. Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBP beta promoter element. J. Biol. Chem. 1993, 268:21931-21938.
392. Piontkewitz Y., Enerback S., Hedin L. Expression of CCAAT enhancer binding protein-alpha (C/EBP alpha) in the rat ovary: implications for follicular development and ovulation. Dev. Biol. 1996, 179:288-296.
393. Roesler W.J., Park E.A., McFie P.J. Characterization of CCAAT/enhancer-binding protein alpha as a cyclic AMP-responsive nuclear regulator. J. Biol. Chem. 1998, 273:14950-14957.
394. Sterneck E., Tessarollo L., Johnson P.F. An essential role for C/EBPbeta in female reproduction. Genes Dev. 1997, 11:2153-2162.
395. Pall M., Hellberg P., Brannstrom M., Mikuni M., Peterson C.M., Sundfeldt K., Norden B., Hedin L., Enerback S. The transcription factor C/EBP-beta and its role in ovarian function; evidence for direct involvement in the ovulatory process. EMBO J. 1997, 16:5273-5279.
396. Berg J.M. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc. Natl. Acad. Sci. U S A 1992, 89:11109-11110.
397. Sugawara T., Lin D., Holt J.A., Martin K.O., Javitt N.B., Miller W.L., Strauss J.F. Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry 1995, 34:12506-12512.
398. Venepally P., Waterman M.R. Two Sp1-binding sites mediate cAMP-induced transcription of the bovine CYP11A gene through the protein kinase A signaling pathway. J. Biol. Chem. 1995, 270:25402-25410.
399. Ahlgren R., Simpson E.R., Waterman M.R., Lund J. Characterization of the promoter/regulatory region of the bovine CYP11A (P-450scc) gene. Basal and cAMP-dependent expression. J. Biol. Chem. 1990, 265:3313-3319.
400. Kagawa N., Waterman M.R. Evidence that an adrenal-specific nuclear protein regulates the cAMP responsiveness of the human CYP21B (P450C21) gene. J. Biol. Chem. 1991, 266:11199-11204.
401. Borroni R., Liu Z., Simpson E.R., Hinshelwood M.M. A putative binding site for Sp1 is involved in transcriptional regulation of CYP17 gene expression in bovine ovary. Endocrinology 1997, 138:2011-2020.
402. Sun G., Porter W., Safe S. Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex. Mol. Endocrinol. 1998, 12:882-890.
403. Lee Y.H., Williams S.C., Baer M., Sterneck E., Gonzalez F.J., Johnson P.F. The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain. Mol. Cell. Biol. 1997, 17:2038-2047.
404. Rodenburg R.J., Holthuizen P.E., Sussenbach J.S. A functional Sp1 binding site is essential for the activity of the adult liver-specific human insulin-like growth factor II promoter. Mol. Endocrinol. 1997, 11:237-250.
405. Shea-Eaton W.K., Trinidad M.J., Lopez D., Nackley A., McLean M.P. Sterol regulatory element binding protein-1a regulation of the steroidogenic acute regulatory protein gene. Endocrinology 2001, 142:1525-1533.
406. Silverman E., Eimerl S., Orly J. CCAAT enhancer-binding protein beta and GATA-4 binding regions within the promoter of the steroidogenic acute regulatory protein (StAR) gene are required for transcription in rat ovarian cells. J. Biol. Chem. 1999, 274:17987-17996.
407. Christenson L.K., McAllister J.M., Martin K.O., Javitt N.B., Osborne T.F., Strauss J.F. Oxysterol regulation of steroidogenic acute regulatory protein gene expression. Structural specificity and transcriptional and posttranscriptional actions. J. Biol. Chem. 1998, 273:30729-30735.
408. Christenson L.K., Osborne T.F., McAllister J.M., Strauss J.F. Conditional response of the human steroidogenic acute regulatory protein gene promoter to sterol regulatory element binding protein-1a. Endocrinology 2001, 142:28-36.
409. Manna P.R., Dyson M.T., Eubank D.W., Clark B.J., Lalli E., Sassone-Corsi P., Zeleznik A.J., Stocco D.M. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol. Endocrinol. 2002, 16:184-199.
410. Sugawara T., Nomura E., Sakuragi N., Fujimoto S. The effect of the arylhydrocarbon receptor on the human steroidogenic acute regulatory gene promoter activity. J. Ster. Biochem. Mol. Biol. 2001, 78:253-260.
411. Meyer T.E., Habener J.F. Cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr. Rev. 1993, 14:269-290.
412. Sassone-Corsi P. Transcription factors responsive to cAMP. Annu. Rev. Cell. Dev. Biol. 1995, 11:355-377.
413. Montminy M. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 1997, 66:807-822.
414. Gonzalez G.A., Menzel P., Leonard J., Fischer W.H., Montminy M.R. Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB. Mol. Cell. Biol. 1991, 11:1306-1312.
415. Della Fazia M.A., Servillo G., Sassone-Corsi P. Cyclic AMP signalling and cellular proliferation: regulation of CREB and CREM. FEBS Lett. 1997, 410:22-24.
416. Manna P.R., Eubank D.W., Lalli E., Sassone-Corsi P., Stocco D.M. Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP response-element binding protein and steroidogenic factor 1. J. Mol. Endocrinol. 2003, 30:381-397.
417. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U S A 1991, 88:3720-3724.
418. Masquilier D., Sassone-Corsi P. Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J. Biol. Chem. 1992, 267:22460-22466.
419. Shea-Eaton W., Sandhoff T.W., Lopez D., Hales D.B., McLean M.P. Transcriptional repression of the rat steroidogenic acute regulatory (StAR) protein gene by the AP-1 family member c-Fos. Mol. Cell. Endocrinol. 2002, 188:161-170.
420. Manna P.R., Eubank D.W., Stocco D.M. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene. Mol. Endocrinol. 2004, 18:558-573.
421. Ikeda Y., Swain A., Weber T.J., Hentges K.E., Zanaria E., Lalli E., Tamai K.T., Sassone-Corsi P., Lovell-Badge R., Camerino G., Parker K.L. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol. Endocrinol. 1996, 10:1261-1272.
422. Swain A., Zanaria E., Hacker A., Lovell-Badge R., Camerino G. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat. Genet. 1996, 12:404-409.
423. Lalli E., Sassone-Corsi P. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol. Endocrinol. 2003, 17:1445-1453.
424. Muscatelli F., Strom T.M., Walker A.P., Zanaria E., Recan D., Meindl A., Bardoni B., Guioli S., Zehetner G., Rabl W., et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994, 372:672-676.
425. Zazopoulos E., Lalli E., Stocco D.M., Sassone-Corsi P. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997, 390:311-315.
426. Lalli E., Melner M.H., Stocco D.M., Sassone-Corsi P. DAX-1 blocks steroid production at multiple levels. Endocrinology 1998, 139:4237-4243.
427. Suzuki T., Kasahara M., Yoshioka H., Morohashi K., Umesono K. LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Mol. Cell. Biol. 2003, 23:238-249.
428. Ito M., Yu R., Jameson J.L. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 1997, 17:1476-1483.
429. Ericsson J., Usheva A., Edwards P.A. YY1 is a negative regulator of transcription of three sterol regulatory element-binding protein-responsive genes. J. Biol. Chem. 1999, 274:14508-14513.
430. Galvin K.M., Shi Y. Multiple mechanisms of transcriptional repression by YY1. Mol. Cell. Biol. 1997, 17:3723-3732.
431. Bennett M.K., Ngo T.T., Athanikar J.N., Rosenfeld J.M., Osborne T.F. Co-stimulation of promoter for low density lipoprotein receptor gene by sterol regulatory element-binding protein and Sp1 is specifically disrupted by the yin yang 1 protein. J. Biol. Chem. 1999, 274:13025-13032.
432. Nackley A.C., Shea-Eaton W., Lopez D., McLean M.P. Repression of the steroidogenic acute regulatory gene by the multifunctional transcription factor Yin Yang 1. Endocrinology 2002, 143:1085-1096.
433. Wilson J.D., Griffin J.E., Russell D.W. Steroid 5 alpha-reductase 2 deficiency. Endocr. Rev. 1993, 14:577-593.
434. Russell D.W., Berman D.M., Bryant J.T., Cala K.M., Davis D.L., Landrum C.P., Prihoda J.S., Silver R.I., Thigpen A.E., Wigley W.C. The molecular genetics of steroid 5 alpha-reductases. Recent Prog. Horm. Res. 1994, 49:275-284.
435. Imperato-McGinley J., Binienda Z., Arthur A., Mininberg D.T., Vaughan E.D., Quimby F.W. The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase. Endocrinology 1985, 116:807-812.
436. George F.W., Peterson K.G. 5 alpha-dihydrotestosterone formation is necessary for embryogenesis of the rat prostate. Endocrinology 1988, 122:1159-1164.
437. Grino P.B., Griffin J.E., Wilson J.D. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 1990, 126:1165-1172.
438. Deslypere J.P., Young M., Wilson J.D., McPhaul M.J. Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol. Cell. Endocrinol. 1992, 88:15-22.
439. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
440. Zoppi S., Young M., McPhaul M. Regulation of gene expression by the nuclear receptor family. Genetics of Steroid Biosynthesis and Function 2002, 376-403. Harwood Academic Publisher, Austin, TX. J. Mason (Ed.).
441. Robinson-Rechavi M., Escriva Garcia H., Laudet V. The nuclear receptor superfamily. J. Cell. Sci. 2003, 116:585-586.
442. Freedman L.P., Luisi B.F. On the mechanism of DNA binding by nuclear hormone receptors: a structural and functional perspective. J. Cell. Biochem. 1993, 51:140-150.
443. Shaffer P.L., Jivan A., Dollins D.E., Claessens F., Gewirth D.T. Structural basis of androgen receptor binding to selective androgen response elements. Proc. Natl. Acad. Sci. U S A 2004, 101:4758-4763.
444. Matias P.M., Donner P., Coelho R., Thomaz M., Peixoto C., Macedo S., Otto N., Joschko S., Scholz P., Wegg A., Basler S., Schafer M., Egner U., Carrondo M.A. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J. Biol. Chem. 2000, 275:26164-26171.
445. Sack J.S., Kish K.F., Wang C., Attar R.M., Kiefer S.E., An Y., Wu G.Y., Scheffler J.E., Salvati M.E., Krystek S.R., Weinmann R., Einspahr H.M. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc. Natl. Acad. Sci. U S A 2001, 98:4904-4909.
446. Matias P.M., Carrondo M.A., Coelho R., Thomaz M., Zhao X.Y., Wegg A., Crusius K., Egner U., Donner P. Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR[ccr]) derived from an androgen-independent prostate cancer. J. Med. Chem. 2002, 45:1439-1446.
447. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
448. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., Yamamoto K.R. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 1998, 12:3343-3356.
449. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95:927-937.
450. He B., Wilson E.M. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs. Mol. Cell. Biol. 2003, 23:2135-2150.
451. Hampsey M., Reinberg D. RNA polymerase II as a control panel for multiple coactivator complexes. Curr. Opin. Genet. Dev. 1999, 9:132-139.
452. Jenster G. Coactivators and corepressors as mediators of nuclear receptor function: an update. Mol. Cell. Endocrinol. 1998, 143:1-7.
453. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 1999, 20:321-344.
454. Heinlein C.A., Chang C. Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 2002, 23:175-200.
455. Taatjes D.J., Marr M.T., Tjian R. Regulatory diversity among metazoan co-activator complexes. Nat. Rev. Mol. Cell. Biol. 2004, 5:403-410.
456. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
457. Shang Y., Myers M., Brown M. Formation of the androgen receptor transcription complex. Mol. Cell. 2002, 9:601-610.
458. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
459. Webb P., Nguyen P., Valentine C., Lopez G.N., Kwok G.R., McInerney E., Katzenellenbogen B.S., Enmark E., Gustafsson J.A., Nilsson S., Kushner P.J. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol. Endocrinol. 1999, 13:1672-1685.
460. De Bosscher K., Vanden Berghe W., Haegeman G. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol. Endocrinol. 2001, 15:219-227.
461. Lobaccaro J.M., Poujol N., Terouanne B., Georget V., Fabre S., Lumbroso S., Sultan C. Transcriptional interferences between normal or mutant androgen receptors and the activator protein 1-dissection of the androgen receptor functional domains. Endocrinology 1999, 140:350-357.
462. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., Shaul P.W. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 1999, 103:401-406.
463. Mendelsohn M.E. Genomic and nongenomic effects of estrogen in the vasculature. Am. J. Cardiol. 2002, 90:3F-6F.
464. Chambliss K.L., Shaul P.W. Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev. 2002, 23:665-686.
465. Coleman K.M., Smith C.L. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci. 2001, 6:D1379-D1391.
466. Castoria G., Barone M.V., Di Domenico M., Bilancio A., Ametrano D., Migliaccio A., Auricchio F. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 1999, 18:2500-2510.
467. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Maller J.L., Miller W.T., Edwards D.P. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell. 2001, 8:269-280.
468. Wong C.W., McNally C., Nickbarg E., Komm B.S., Cheskis B.J. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc. Natl. Acad. Sci. U S A 2002, 99:14783-14788.
469. Lutz L.B., Jamnongjit M., Yang W.H., Jahani D., Gill A., Hammes S.R. Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol. Endocrinol. 2003, 17:1106-1116.
470. Unni E., Sun S., Nan B., McPhaul M., Cheskis B.J., Mancini M., Marcelli M. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res. 2004, 64(19):7156-7168.
471. Donjacour A.A., Thomson A.A., Cunha G.R. FGF-10 plays an essential role in the growth of the fetal prostate. Dev. Biol. 2003, 261:39-54.
472. Gerdes M.J., Larsen M., Dang T.D., Ressler S.J., Tuxhorn J.A., Rowley D.R. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1. Prostate 2004, 58:299-307.
473. Cunha G.R. Growth factors as mediators of androgen action during male urogenital development. Prostate Suppl. 1996, 6:22-25.
474. Thomson A.A. Role of androgens and fibroblast growth factors in prostatic development. Reproduction 2001, 121:187-195.
475. Verhoeven G., Hoeben E., De Gendt K. Peritubular cell-Sertoli cell interactions: factors involved in PmodS activity. Andrologia 2000, 32:42-45.
476. Lyon M.F., Glenister P.H., Lamoreux M.L. Normal spermatozoa from androgen-resistant germ cells of chimaeric mice and the role of androgen in spermatogenesis. Nature 1975, 258:620-622.
477. Johnston D.S., Russell L.D., Friel P.J., Griswold M.D. Murine germ cells do not require functional androgen receptors to complete spermatogenesis following spermatogonial stem cell transplantation. Endocrinology 2001, 142:2405-2408.
478. Sar M., Lubahn D.B., French F.S., Wilson E.M. Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 1990, 127:3180-3186.
479. Bremner W.J., Millar M.R., Sharpe R.M., Saunders P.T. Immunohistochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens. Endocrinology 1994, 135:1227-1234.
480. Vornberger W., Prins G., Musto N.A., Suarez-Quian C.A. Androgen receptor distribution in rat testis: new implications for androgen regulation of spermatogenesis. Endocrinology 1994, 134:2307-2316.
481. Suarez-Quian C.A., Martinez-Garcia F., Nistal M., Regadera J. Androgen receptor distribution in adult human testis. J. Clin. Endocrinol. Metab. 1999, 84:350-358.
482. Van Roijen J.H., Van Assen S., Van Der Kwast T.H., De Rooij D.G., Boersma W.J., Vreeburg J.T., Weber R.F. Androgen receptor
483. Goyal H.O., Bartol F.F., Wiley A.A., Khalil M.K., Chiu J., Vig M.M. Immunolocalization of androgen receptor and estrogen receptor in the developing testis and excurrent ducts of goats. Anat. Rec. 1997, 249:54-62.
484. Kimura N., Mizokami A., Oonuma T., Sasano H., Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J. Histochem. Cytochem. 1993, 41:671-678.
485. Zhou X., Kudo A., Kawakami H., Hirano H. Immunohistochemical localization of androgen receptor in mouse testicular germ cells during fetal and postnatal development. Anat. Rec. 1996, 245:509-518.
486. Pelletier G., Labrie C., Labrie F. Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs. J. Endocrinol. 2000, 165:359-370.
487. Zhu L.J., Hardy M.P., Inigo I.V., Huhtaniemi I., Bardin C.W., Moo-Young A.J. Effects of androgen on androgen receptor expression in rat testicular and epididymal cells: a quantitative immunohistochemical study. Biol. Reprod. 2000, 63:368-376.
488. Zhou Q., Nie R., Prins G.S., Saunders P.T., Katzenellenbogen B.S., Hess R.A. Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J. Androl. 2002, 23:870-881.
489. Saunders P., Millar M., Majdic G., Bremner W., McLaren T., Grigor K., Sharpe R. Testicular androgen receptor protein: distribution and control of expression. Cellular and Molecular Regulation of Testicular Cells 1996, 213-229. Springer Verlag. C. Desjardins (Ed.).
490. Sharpe R.M., Maddocks S., Millar M., Kerr J.B., Saunders P.T., McKinnell C. Testosterone and spermatogenesis. Identification of stage-specific, androgen-regulated proteins secreted by adult rat seminiferous tubules. J. Androl. 1992, 13:172-184.
491. Russell L.D., Clermont Y. Degeneration of germ cells in normal, hypophysectomized and hormone treated hypophysectomized rats. Anat. Rec. 1977, 187:347-366.
492. Bartlett J.M., Kerr J.B., Sharpe R.M. The effect of selective destruction and regeneration of rat Leydig cells on the intratesticular distribution of testosterone and morphology of the seminiferous epithelium. J. Androl. 1986, 7:240-253.
493. Dym M., Raj H.G. Response of adult rat Sertoli cells and Leydig cells to depletion of luteinizing hormone and testosterone. Biol. Reprod. 1977, 17:676-696.
494. McKinnell C., Sharpe R.M. Testosterone and spermatogenesis: evidence that androgens regulate cellular secretory mechanisms in stage VI-VIII seminiferous tubules from adult rats. J. Androl. 1995, 16:499-509.
495. McLachlan R.I., O'Donnell L., Meachem S.J., Stanton P.G., de Kretser D.M., Pratis K., Robertson D.M. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog. Horm. Res. 2002, 57:149-179.
496. De Gendt K., Swinnen J.V., Saunders P.T., Schoonjans L., Dewerchin M., Devos A., Tan K., Atanassova N., Claessens F., Lecureuil C., Heyns W., Carmeliet P., Guillou F., Sharpe R.M., Verhoeven G. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc. Natl. Acad. Sci. U S A 2004, 101:1327-1332.